File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1080/10428190701625081
- Scopus: eid_2-s2.0-36049001925
- PMID: 17926176
- WOS: WOS:000250839100023
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Prolonged oral arsenic trioxide therapy and neprholithiasis [1]
Title | Prolonged oral arsenic trioxide therapy and neprholithiasis [1] |
---|---|
Authors | |
Issue Date | 2007 |
Publisher | Informa Healthcare. The Journal's web site is located at http://informahealthcare.com/loi/lal |
Citation | Leukemia And Lymphoma, 2007, v. 48 n. 11, p. 2233-2234 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/163127 |
ISSN | 2023 Impact Factor: 2.2 2023 SCImago Journal Rankings: 0.790 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Au, WY | en_US |
dc.contributor.author | Tam, S | en_US |
dc.contributor.author | Fong, B | en_US |
dc.contributor.author | Ho, KL | en_US |
dc.contributor.author | Tam, PC | en_US |
dc.contributor.author | Kwong, YL | en_US |
dc.date.accessioned | 2012-09-05T05:27:57Z | - |
dc.date.available | 2012-09-05T05:27:57Z | - |
dc.date.issued | 2007 | en_US |
dc.identifier.citation | Leukemia And Lymphoma, 2007, v. 48 n. 11, p. 2233-2234 | en_US |
dc.identifier.issn | 1042-8194 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/163127 | - |
dc.language | eng | en_US |
dc.publisher | Informa Healthcare. The Journal's web site is located at http://informahealthcare.com/loi/lal | en_US |
dc.relation.ispartof | Leukemia and Lymphoma | en_US |
dc.rights | Leukemia and Lymphoma . Copyright © Informa Healthcare. | - |
dc.subject.mesh | Administration, Oral | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Aged, 80 And Over | en_US |
dc.subject.mesh | Antineoplastic Agents - Administration & Dosage - Adverse Effects | en_US |
dc.subject.mesh | Arsenic - Urine | en_US |
dc.subject.mesh | Arsenic Poisoning - Complications - Urine | en_US |
dc.subject.mesh | Arsenicals - Administration & Dosage - Adverse Effects | en_US |
dc.subject.mesh | Case-Control Studies | en_US |
dc.subject.mesh | Drug Administration Schedule | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Leukemia, Promyelocytic, Acute - Drug Therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Nephrolithiasis - Chemically Induced | en_US |
dc.subject.mesh | Oxides - Administration & Dosage - Adverse Effects | en_US |
dc.subject.mesh | Time Factors | en_US |
dc.title | Prolonged oral arsenic trioxide therapy and neprholithiasis [1] | en_US |
dc.type | Article | en_US |
dc.identifier.email | Kwong, YL:ylkwong@hku.hk | en_US |
dc.identifier.authority | Kwong, YL=rp00358 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1080/10428190701625081 | en_US |
dc.identifier.pmid | 17926176 | - |
dc.identifier.scopus | eid_2-s2.0-36049001925 | en_US |
dc.identifier.hkuros | 145674 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-36049001925&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 48 | en_US |
dc.identifier.issue | 11 | en_US |
dc.identifier.spage | 2233 | en_US |
dc.identifier.epage | 2234 | en_US |
dc.identifier.isi | WOS:000250839100023 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Au, WY=7202383089 | en_US |
dc.identifier.scopusauthorid | Tam, S=7202037323 | en_US |
dc.identifier.scopusauthorid | Fong, B=16507017100 | en_US |
dc.identifier.scopusauthorid | Ho, KL=35763728100 | en_US |
dc.identifier.scopusauthorid | Tam, PC=7202539419 | en_US |
dc.identifier.scopusauthorid | Kwong, YL=7102818954 | en_US |
dc.identifier.issnl | 1026-8022 | - |